Skip to main content

Precision Medicine

Workforce
By Kat Jercich | 05:22 pm | November 24, 2020
The partnership will use de-identified patient data to zero in on factors that worsen COVID-19 outcomes among certain groups.
05:37 pm | November 18, 2020
S4S pilot project participants noted that research requirements can affect the ability to adopt third-party apps, among other barriers to broader adoption of patient-directed data sharing.  
HIMSS Middle East 2020
By Rachel McArthur | 11:55 am | November 11, 2020
Both will work together to accelerate the growth of transformational healthcare companies across markets in the Middle East and North African, and the Association of South-East Asian Nations.
By Mike Miliard | 03:57 pm | October 06, 2020
Working with AWS, researchers from UPMC, the University of Pittsburgh, and Carnegie Mellon are building new machine learning tools for breast cancer and depression screening.
SPONSORED HIMSS Europe 2020
By Roche | 06:55 am | September 10, 2020
The extent to which the world of digital health has changed during the COVID-19 pandemic has been widely recognised.
By Kat Jercich | 01:06 pm | September 08, 2020
The ADT-based collaboration network will collaborate with the Hospital Industry Data Institute to support delivery of near real-time data to Missouri care teams.
HIMSS Europe 2020
By Rosy Matheson | 12:52 pm | September 08, 2020
Shifting the focus from acute to preventative health and care is the ultimate aim for the digital transformation of health systems globally. Precision health integrates health insights and social determinants to improve clinical and financial outcomes.
By Mike Miliard | 11:15 am | August 26, 2020
Dragon Medical One voice technology will be integrated with mCODE core data, enabling easier documentation within clinical workflows – and a new partnership with Mayo will explore automation opportunities.
By Charles Alessi | 03:51 am | August 12, 2020
Health and care have been inexorably moving toward a new paradigm – one where the nature of the interactions is more personalised and they require the person to be more active in their pursuit of reducing risks that have an adverse effect upon the development of non-communicable diseases, says Dr Charles Alessi, chief clinical officer at HIMSS.
By Kat Jercich | 01:41 pm | July 07, 2020
The U.S. Department of Health and Human Services also announced it would give $450 million to the biotech company Regeneron to manufacture and supply the company's antibody treatment.